FDA's Framework for Decentralized Clinical Trials
![GMP meets Development](files/eca/userImages/training.img/Z-ECA-GMP-meets-Development.jpg)
Recommendation
5-7 November 2024
Hamburg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
Following the previously published guidance on externally controlled trials, the U.S. Food and Drug Administration (FDA) issued a Framework for the use of Digital Health Technologies (DHT). The DHT document will guide the use of DHT-derived data in regulatory decision-making for drugs and biological products. The document outlines the framework the agency will use to
- Implement a multifaceted DHT program;
- Engage stakeholders;
- Establish internal processes to support DHT evaluation;
- Promote shared learning and consistency for DHT-based policy, procedure, and analytic tool development;
- Facilitate the publication of relevant guidance documents.
DHTs can enable the conduct of decentralized clinical trials, where data can be remotely recorded and analyzed directly from participants as part of everyday tasks wherever the participants may be (e.g., at home, school, work, or outdoors). DHTs can also help in collecting data from participants who are unable to report their experiences like infants or cognitively impaired individuals. This type of data collection can improve trial retention rates by enhancing convenience for trial participants and reducing the burden on caregivers.
For detailed information, please see the Digital Health Technologies for Drug Development webpage. For information on the framework and how to comment, please see the Federal Register Notice.
Related GMP News
20.06.2024Draft ICH M14 Guideline on Real-World Data for Safety Assessment
20.06.2024Glossary of Terms and Definitions for Innovative Clinical Trials
21.05.2024Real-World Evidence: FDA´s Considerations for Non-Interventional Studies
14.05.2024How to Handle and Reserve Samples from BA / BE Studies
16.04.2024FDA issues Draft Guidance on Key Information in Informed Consent
14.03.2024Improving Registration and Reporting Summary Results Information for Clinical Trials